Company: BIAF
Filing Date: 2025-05-23
Form Type: PRER14A
Source: 0001641172-25-012315
Chunk: 19

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-23
Form: PRER14A
Chunk 19
---
     | Director (1) (3)                                 |
| Peter Knight(4)  |     |     | 74 |     | May 2018       |     | Director (1*)                                    
 (2*) (3)                                         |
| Gary Rubin       |     |     | 69 |     | October 2017   |     | Director (1) (3*)                                |
| Roby Joyce, MD   |     |     | 77 |     | September 2023 |     | Director                                         |
| Jamie Platt, PhD |     |     | 58 |     | December 2023  |     | Director (2)                                     |

| (1) | Member of the Audit Committee.                                                                                                        |
| (2) | Member of the Compensation Committee.                                                                                                 |
| (3) | Member of the Nominating and Corporate Governance Committee                                                                           |
| (4) | Peter Knight is not a current member of the Audit Committee,                                                                          
 but the Board has appointed him as a member and Chairman of the Audit Committee effective as of the conclusion of the Annual Meeting. |
| *   | Committee Chairman                                                                                                                    |

| 10 |

The business experience, qualifications, attributes,
and skills that led the Nominating and Corporate Governance Committee to nominate each director nominee are provided below.

Director Qualifications and Experience

In determining which director nominees to nominate
for election to the Board, the Board considered an array of factors related to each nominee’s primary experience, qualifications,
attributes, and skills. Among such factors, the Board evaluated each nominee’s professional standing in the nominee’s chosen
field, experience in financial services or related industries, experience reviewing financial statements and financial matters, civic
and community involvement, qualification for director independence, leadership and team building skills, diversity by race, gender, or
culture, degree of collegiality and insightfulness, and stock ownership in the Company.

Director Biographical Information

The biographical information of each
director nominee is included in this Proxy Statement under “Directors, Executive Officers, and Corporate Governance
– Biographical Information.”

Vote Required

If a quorum exists, the nominees for director receiving
a majority of the votes cast (i.e., the number of shares voted “for” a director nominee exceeds the number of votes cast “against”
that nominee), will be elected as directors. Abstentions and broker non-votes are not votes cast and will have no effect on the outcome
of this vote.

<div align='center'>THE BOARD